Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications.
Geist
Marcus J P
MJ
Egerer
Gerlinde
G
Burhenne
Jürgen
J
Riedel
Klaus-Dieter
KD
Mikus
Gerd
G
D000904:Antibiotics, Antitubercular / Q000009:adverse effects*; D000935:Antifungal Agents / Q000378:metabolism* / Q000493:pharmacokinetics; D019540:Area Under Curve; D003142:Communication; D004347:Drug Interactions; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications / Q000378:metabolism*; D008508:Medication Errors / Q000517:prevention & control*; D011743:Pyrimidines / Q000378:metabolism* / Q000493:pharmacokinetics; D012293:Rifampin / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000382:microbiology; D014230:Triazoles / Q000378:metabolism* / Q000493:pharmacokinetics; D065819:Voriconazole
D000904:Antibiotics, Antitubercular; D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole; D012293:Rifampin